Predicting recurrence-free survival after surgery for GIST
Gespeichert in:
| Veröffentlicht in: | The lancet oncology 2009-11, Vol.10 (11), p.1025-1025 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1025 |
|---|---|
| container_issue | 11 |
| container_start_page | 1025 |
| container_title | The lancet oncology |
| container_volume | 10 |
| creator | Joensuu, Heikki |
| description | |
| doi_str_mv | 10.1016/S1470-2045(09)70267-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734118644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1470204509702670</els_id><sourcerecordid>1895158391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-1f5d4f661f57199d199a83eeaa9fe46ce415bdb1840cf008fe7042c05ae596bb3</originalsourceid><addsrcrecordid>eNqFkFFr1TAUx4Mobk4_glJ8cT5Uz0mTpvFBGUPnYKCw-RzS9GRk9rZb0l6439709qKwFx_CScLv_E_yY-w1wgcErD9eo1BQchDyFPR7BbxWJTxhx_lalFI0zdP9fkWO2IuU7gBQIcjn7Ai10lWt1DH79DNSF9wUhtsikptjpMFR6SNRkea4DVvbF9ZPFJfjLcVd4cdYXFxe37xkz7ztE7061BP269vXm_Pv5dWPi8vzs6vSSeRTiV52wtd1rgq17vKyTUVkrfYkakcCZdu12AhwHqDxpEBwB9KS1HXbVifs3Zp7H8eHmdJkNiE56ns70DgnoyqB2NRCZPLtI_JunOOQH2c4IHDkHDIkV8jFMaVI3tzHsLFxZxDMotbs1ZrFmwFt9mrN0vfmED63G-r-dR1cZuDLClCWsQ0UTXJhsdmFbHYy3Rj-O-LzowTXhyE42_-mHaW_n0GTuIE1ZMkAvU-A6g-PV5vm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201021220</pqid></control><display><type>article</type><title>Predicting recurrence-free survival after surgery for GIST</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Joensuu, Heikki</creator><creatorcontrib>Joensuu, Heikki</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(09)70267-0</identifier><identifier>PMID: 19793677</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antineoplastic Agents - therapeutic use ; Benzamides ; Chemotherapy, Adjuvant ; Digestive System Surgical Procedures ; Disease-Free Survival ; Gastrointestinal Stromal Tumors - drug therapy ; Gastrointestinal Stromal Tumors - mortality ; Gastrointestinal Stromal Tumors - secondary ; Gastrointestinal Stromal Tumors - surgery ; Hematology, Oncology and Palliative Medicine ; Humans ; Imatinib Mesylate ; Mitotic Index ; Neoplasm Invasiveness ; Neoplasm Staging ; Nomograms ; Patient Selection ; Piperazines - therapeutic use ; Predictive Value of Tests ; Protein Kinase Inhibitors - therapeutic use ; Pyrimidines - therapeutic use ; Reproducibility of Results ; Risk Assessment ; Time Factors ; Treatment Outcome</subject><ispartof>The lancet oncology, 2009-11, Vol.10 (11), p.1025-1025</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Nov 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-1f5d4f661f57199d199a83eeaa9fe46ce415bdb1840cf008fe7042c05ae596bb3</citedby><cites>FETCH-LOGICAL-c512t-1f5d4f661f57199d199a83eeaa9fe46ce415bdb1840cf008fe7042c05ae596bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1470204509702670$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19793677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joensuu, Heikki</creatorcontrib><title>Predicting recurrence-free survival after surgery for GIST</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><subject>Antineoplastic Agents - therapeutic use</subject><subject>Benzamides</subject><subject>Chemotherapy, Adjuvant</subject><subject>Digestive System Surgical Procedures</subject><subject>Disease-Free Survival</subject><subject>Gastrointestinal Stromal Tumors - drug therapy</subject><subject>Gastrointestinal Stromal Tumors - mortality</subject><subject>Gastrointestinal Stromal Tumors - secondary</subject><subject>Gastrointestinal Stromal Tumors - surgery</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Imatinib Mesylate</subject><subject>Mitotic Index</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Staging</subject><subject>Nomograms</subject><subject>Patient Selection</subject><subject>Piperazines - therapeutic use</subject><subject>Predictive Value of Tests</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Pyrimidines - therapeutic use</subject><subject>Reproducibility of Results</subject><subject>Risk Assessment</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkFFr1TAUx4Mobk4_glJ8cT5Uz0mTpvFBGUPnYKCw-RzS9GRk9rZb0l6439709qKwFx_CScLv_E_yY-w1wgcErD9eo1BQchDyFPR7BbxWJTxhx_lalFI0zdP9fkWO2IuU7gBQIcjn7Ai10lWt1DH79DNSF9wUhtsikptjpMFR6SNRkea4DVvbF9ZPFJfjLcVd4cdYXFxe37xkz7ztE7061BP269vXm_Pv5dWPi8vzs6vSSeRTiV52wtd1rgq17vKyTUVkrfYkakcCZdu12AhwHqDxpEBwB9KS1HXbVifs3Zp7H8eHmdJkNiE56ns70DgnoyqB2NRCZPLtI_JunOOQH2c4IHDkHDIkV8jFMaVI3tzHsLFxZxDMotbs1ZrFmwFt9mrN0vfmED63G-r-dR1cZuDLClCWsQ0UTXJhsdmFbHYy3Rj-O-LzowTXhyE42_-mHaW_n0GTuIE1ZMkAvU-A6g-PV5vm</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Joensuu, Heikki</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20091101</creationdate><title>Predicting recurrence-free survival after surgery for GIST</title><author>Joensuu, Heikki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-1f5d4f661f57199d199a83eeaa9fe46ce415bdb1840cf008fe7042c05ae596bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Benzamides</topic><topic>Chemotherapy, Adjuvant</topic><topic>Digestive System Surgical Procedures</topic><topic>Disease-Free Survival</topic><topic>Gastrointestinal Stromal Tumors - drug therapy</topic><topic>Gastrointestinal Stromal Tumors - mortality</topic><topic>Gastrointestinal Stromal Tumors - secondary</topic><topic>Gastrointestinal Stromal Tumors - surgery</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Imatinib Mesylate</topic><topic>Mitotic Index</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Staging</topic><topic>Nomograms</topic><topic>Patient Selection</topic><topic>Piperazines - therapeutic use</topic><topic>Predictive Value of Tests</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Pyrimidines - therapeutic use</topic><topic>Reproducibility of Results</topic><topic>Risk Assessment</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joensuu, Heikki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joensuu, Heikki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting recurrence-free survival after surgery for GIST</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>10</volume><issue>11</issue><spage>1025</spage><epage>1025</epage><pages>1025-1025</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><coden>LANCAO</coden><cop>England</cop><pub>Elsevier Ltd</pub><pmid>19793677</pmid><doi>10.1016/S1470-2045(09)70267-0</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-2045 |
| ispartof | The lancet oncology, 2009-11, Vol.10 (11), p.1025-1025 |
| issn | 1470-2045 1474-5488 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734118644 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Antineoplastic Agents - therapeutic use Benzamides Chemotherapy, Adjuvant Digestive System Surgical Procedures Disease-Free Survival Gastrointestinal Stromal Tumors - drug therapy Gastrointestinal Stromal Tumors - mortality Gastrointestinal Stromal Tumors - secondary Gastrointestinal Stromal Tumors - surgery Hematology, Oncology and Palliative Medicine Humans Imatinib Mesylate Mitotic Index Neoplasm Invasiveness Neoplasm Staging Nomograms Patient Selection Piperazines - therapeutic use Predictive Value of Tests Protein Kinase Inhibitors - therapeutic use Pyrimidines - therapeutic use Reproducibility of Results Risk Assessment Time Factors Treatment Outcome |
| title | Predicting recurrence-free survival after surgery for GIST |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T17%3A25%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20recurrence-free%20survival%20after%20surgery%20for%20GIST&rft.jtitle=The%20lancet%20oncology&rft.au=Joensuu,%20Heikki&rft.date=2009-11-01&rft.volume=10&rft.issue=11&rft.spage=1025&rft.epage=1025&rft.pages=1025-1025&rft.issn=1470-2045&rft.eissn=1474-5488&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1470-2045(09)70267-0&rft_dat=%3Cproquest_cross%3E1895158391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201021220&rft_id=info:pmid/19793677&rft_els_id=1_s2_0_S1470204509702670&rfr_iscdi=true |